Profile data is unavailable for this security.
About the company
Alphamab Oncology is an investment holding company primarily engaged in the biopharmaceutical business. The Company is a full-industry chain enterprise specializing in research, development, manufacture, and commercialization of innovative tumor immunobiology macromolecular targeted drugs. The Company has bio-innovation drug development technology platform, including protein engineering platform, multi-functional antibody development platform and antibody screening platform. The Company operates its businesses in both domestic and overseas markets.
- Revenue in HKD (TTM)235.99m
- Net income in HKD-227.16m
- Incorporated2018
- Employees435.00
- LocationAlphamab OncologyNo. 175Fangzhou Road, Suzhou Industrial ParkSuzhou 215125ChinaCHN
- Phone+86 51 262850800
- Websitehttps://www.alphamabonc.com/en/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Isotope & Radiation Corp | 7.16bn | 400.15m | 3.49bn | 3.11k | 8.71 | 0.6887 | 3.22 | 0.4872 | 1.25 | 1.25 | 22.37 | 15.83 | 0.5312 | 4.22 | 1.84 | 2,304,991.00 | 6.21 | 6.57 | 12.82 | 13.26 | 52.48 | 59.89 | 11.70 | 12.62 | 1.73 | -- | 0.1919 | 28.27 | 7.82 | 15.35 | -5.43 | 2.88 | 3.63 | 2.92 |
| CARsgen Therapeutics Holdings Ltd | 0.00 | -806.63m | 3.83bn | 516.00 | -- | 1.97 | -- | -- | -1.45 | -1.45 | 0.00 | 3.38 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
| Biocytogen Pharmaceuticals Beijng Co Ltd | 773.31m | -413.08m | 3.83bn | 1.07k | -- | 4.52 | -- | 4.95 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 725,435.90 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
| CK Life Sciences Intl (Holdings) Inc | 5.32bn | 17.25m | 3.89bn | 1.93k | 226.26 | 0.9292 | 34.33 | 0.7313 | 0.0018 | 0.0018 | 0.5538 | 0.4359 | 0.4728 | 2.96 | 4.74 | 2,755,038.00 | 0.1532 | 1.11 | 0.211 | 1.43 | 30.76 | 30.52 | 0.3241 | 2.42 | 0.8512 | 0.8796 | 0.5861 | 59.00 | 0.8936 | 0.3407 | -86.93 | -42.01 | 0.2784 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -268.97m | 4.14bn | 133.00 | -- | 3.76 | -- | -- | -1.34 | -1.34 | 0.00 | 5.44 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 6.41 | -- | 0.0185 | -- | -- | -- | 65.62 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -616.96m | 4.35bn | 472.00 | -- | 3.73 | -- | -- | -1.28 | -1.28 | 0.00 | 2.41 | 0.00 | -- | -- | 0.00 | -25.47 | -- | -30.68 | -- | -- | -- | -- | -- | 2.33 | -- | 0.378 | -- | -- | -- | 20.86 | -- | -- | -- |
| Alphamab Oncology | 235.99m | -227.16m | 4.64bn | 435.00 | -- | 2.57 | -- | 19.67 | -0.2362 | -0.2362 | 0.2458 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,496.40 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
| Ocumension Therapeutics | 265.75m | -409.67m | 4.73bn | 444.00 | -- | 1.49 | -- | 17.80 | -0.6313 | -0.6313 | 0.4094 | 4.56 | 0.078 | 3.61 | 2.12 | 598,535.60 | -12.03 | -38.78 | -13.21 | -41.47 | 58.60 | 62.30 | -154.16 | -975.82 | 3.72 | -- | 0.0451 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Shandong Boan Biotechnology Co Ltd | 666.76m | -128.77m | 4.99bn | 813.00 | -- | 3.51 | -- | 7.49 | -0.2528 | -0.2528 | 1.31 | 2.80 | 0.2732 | 1.35 | 2.53 | 820,123.00 | -5.28 | -- | -7.02 | -- | 66.16 | -- | -19.31 | -- | 0.8383 | -7.47 | 0.2491 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
| Microport NeuroTech Ltd | -100.00bn | -100.00bn | 5.29bn | 571.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 21.61 | -- | 768.73 | -- | -- | -- |
| Sihuan Pharmaceutical Holdings Group Ltd | 2.01bn | -58.27m | 5.32bn | 2.87k | -- | 1.11 | -- | 2.65 | -0.0063 | -0.0063 | 0.2159 | 0.5124 | 0.1572 | 0.8101 | 4.72 | 698,786.90 | -2.18 | -6.85 | -3.34 | -9.10 | 69.64 | 75.81 | -13.85 | -36.23 | 1.35 | -2.63 | 0.1863 | -- | -14.70 | -8.60 | 97.23 | -- | 0.9325 | -- |
| Ascentage Pharma Group International | 239.45m | -998.46m | 5.34bn | 583.00 | -- | 81.93 | -- | 22.30 | -3.53 | -3.53 | 0.8482 | 0.2246 | 0.0833 | 2.38 | 2.22 | 410,717.80 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 5.54bn | 145.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
| Consun Pharmaceutical Group Ltd | 2.79bn | 846.26m | 5.69bn | 3.13k | 6.57 | 1.44 | 6.11 | 2.04 | 1.06 | 1.06 | 3.50 | 4.82 | 0.4981 | 2.08 | 9.10 | 893,473.30 | 15.13 | 12.04 | 22.57 | 19.25 | 74.19 | 74.55 | 30.37 | 24.89 | 2.62 | -- | 0.1155 | 41.53 | 10.71 | 7.03 | 14.88 | 11.01 | -- | 18.43 |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 872.90m | 110.23m | 6.20bn | 948.00 | 19.61 | 0.8551 | -- | 7.10 | 0.1071 | 0.1071 | 0.829 | 2.46 | 0.2852 | 1.44 | 1.62 | 920,779.30 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Qyuns Therapeutics Co Ltd | 0.00 | -547.69m | 6.25bn | 331.00 | -- | 19.66 | -- | -- | -2.47 | -2.47 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
Data as of May 28 2024. Currency figures normalised to Alphamab Oncology's reporting currency: Hong Kong Dollar HKD
7.90%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 09 May 2024 | 23.84m | 2.47% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 16.02m | 1.66% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 11.95m | 1.24% |
| First Seafront Fund Management Co., Ltd.as of 31 Dec 2023 | 8.52m | 0.88% |
| BlackRock Fund Advisorsas of 09 May 2024 | 6.49m | 0.67% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 3.31m | 0.34% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 2.19m | 0.23% |
| BlackRock Advisors (UK) Ltd.as of 09 May 2024 | 1.74m | 0.18% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 1.18m | 0.12% |
| E Fund Asset Management Co. Ltd.as of 31 Dec 2023 | 968.00k | 0.10% |
More ▼
Data from 31 Dec 2023 - 22 May 2024Source: FactSet Research Systems Inc.
